Association of neuromuscular reversal drug with postoperative pulmonary complications in bronchoscopy: definitional challenges.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 40348680.
- Also identified by DOI 10.1016/j.bja.2025.04.005 and PMC identifier 12226754.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A recent retrospective study examined a composite of postoperative pulmonary complications after neostigmine or sugammadex for reversal of neuromuscular block in patients undergoing interventional pulmonology and bronchoscopic procedures. This study reviewed the electronic medical records of 8557 patients across hospitals within a single health system, finding an increased risk of a composite of postoperative pulmonary complications in those receiving sugammadex (odds ratio 1.44; 95% confidence interval: 1.02-2.05). We discuss the challenge of interpreting conflicting findings in the contemporary perioperative literature arising from heterogeneous definitions of postoperative pulmonary complications.
Medical subject headings
- Bronchoscopy
- Sugammadex
- Postoperative Complications
- Lung Diseases
- Neostigmine
- Neuromuscular Blockade